lobbying_activities: 1227883

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1227883	c9bd38de-87f6-41f7-867d-2ae233e2bdfc	Q1	MEHLMAN CONSULTING, INC.	284950	NATIONAL VENTURE CAPITAL ASSOCIATION	2012	first_quarter	MED	FDA reform: Changes to PDUFA (Prescription Drug User Fee Act) and MDUFA (Medical Device User Fee Act) programs. H.R. 4132, Faster Access to Specialized Treatments (FAST) Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act; H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011; S. 2236, Advancing Breakthrough Therapies for Patients Act of 2012	Executive Office of the President (EOP),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of	60000		0	0	2012-04-16T13:06:09.617000-04:00